These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 20492447)
1. Toward the discovery of new agents able to inhibit the expression of microsomal prostaglandin E synthase-1 enzyme as promising tools in drug development. De Simone R; Andrés RM; Aquino M; Bruno I; Guerrero MD; Terencio MC; Paya M; Riccio R Chem Biol Drug Des; 2010 Jul; 76(1):17-24. PubMed ID: 20492447 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological evaluation of a selected library of new potential anti-inflammatory agents bearing the gamma-hydroxybutenolide scaffold: a new class of inhibitors of prostanoid production through the selective modulation of microsomal prostaglandin E synthase-1 expression. Guerrero MD; Aquino M; Bruno I; Terencio MC; Paya M; Riccio R; Gomez-Paloma L J Med Chem; 2007 May; 50(9):2176-84. PubMed ID: 17407277 [TBL] [Abstract][Full Text] [Related]
3. Development of a second generation of inhibitors of microsomal prostaglandin E synthase 1 expression bearing the gamma-hydroxybutenolide scaffold. Aquino M; Guerrero MD; Bruno I; Terencio MC; Paya M; Riccio R Bioorg Med Chem; 2008 Oct; 16(19):9056-64. PubMed ID: 18790649 [TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide-induced expression of microsomal prostaglandin E synthase-1 mediates late-phase PGE2 production in bone marrow derived macrophages. Xiao L; Ornatowska M; Zhao G; Cao H; Yu R; Deng J; Li Y; Zhao Q; Sadikot RT; Christman JW PLoS One; 2012; 7(11):e50244. PubMed ID: 23226252 [TBL] [Abstract][Full Text] [Related]
5. Identification of new γ-hydroxybutenolides that preferentially inhibit the activity of mPGES-1. De Simone R; Bruno I; Riccio R; Stadler K; Bauer J; Schaible AM; Laufer S; Werz O Bioorg Med Chem; 2012 Aug; 20(16):5012-6. PubMed ID: 22795900 [TBL] [Abstract][Full Text] [Related]
6. Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor. Mbalaviele G; Pauley AM; Shaffer AF; Zweifel BS; Mathialagan S; Mnich SJ; Nemirovskiy OV; Carter J; Gierse JK; Wang JL; Vazquez ML; Moore WM; Masferrer JL Biochem Pharmacol; 2010 May; 79(10):1445-54. PubMed ID: 20067770 [TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory and analgesic activity of a novel inhibitor of microsomal prostaglandin E synthase-1 expression. Guerrero MD; Aquino M; Bruno I; Riccio R; Terencio MC; Payá M Eur J Pharmacol; 2009 Oct; 620(1-3):112-9. PubMed ID: 19686718 [TBL] [Abstract][Full Text] [Related]
8. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation. Xu D; Rowland SE; Clark P; Giroux A; Côté B; Guiral S; Salem M; Ducharme Y; Friesen RW; Méthot N; Mancini J; Audoly L; Riendeau D J Pharmacol Exp Ther; 2008 Sep; 326(3):754-63. PubMed ID: 18524979 [TBL] [Abstract][Full Text] [Related]
9. Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders. Koeberle A; Werz O Biochem Pharmacol; 2015 Nov; 98(1):1-15. PubMed ID: 26123522 [TBL] [Abstract][Full Text] [Related]
10. Liver X receptor ligands inhibit the lipopolysaccharide-induced expression of microsomal prostaglandin E synthase-1 and diminish prostaglandin E2 production in murine peritoneal macrophages. Ninomiya Y; Yasuda T; Kawamoto M; Yuge O; Okazaki Y J Steroid Biochem Mol Biol; 2007 Jan; 103(1):44-50. PubMed ID: 17049841 [TBL] [Abstract][Full Text] [Related]
11. Competitive enzymatic interactions determine the relative amounts of prostaglandins E2 and D2. Yu R; Xiao L; Zhao G; Christman JW; van Breemen RB J Pharmacol Exp Ther; 2011 Nov; 339(2):716-25. PubMed ID: 21865441 [TBL] [Abstract][Full Text] [Related]
14. Microparticles stimulate the synthesis of prostaglandin E(2) via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1. Jüngel A; Distler O; Schulze-Horsel U; Huber LC; Ha HR; Simmen B; Kalden JR; Pisetsky DS; Gay S; Distler JH Arthritis Rheum; 2007 Nov; 56(11):3564-74. PubMed ID: 17968936 [TBL] [Abstract][Full Text] [Related]
15. Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1. Wu TY; Juteau H; Ducharme Y; Friesen RW; Guiral S; Dufresne L; Poirier H; Salem M; Riendeau D; Mancini J; Brideau C Bioorg Med Chem Lett; 2010 Dec; 20(23):6978-82. PubMed ID: 20965723 [TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship of nonacidic quinazolinone inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1). Rörsch F; Buscató E; Deckmann K; Schneider G; Schubert-Zsilavecz M; Geisslinger G; Proschak E; Grösch S J Med Chem; 2012 Apr; 55(8):3792-803. PubMed ID: 22449023 [TBL] [Abstract][Full Text] [Related]
17. [Effect of luteolin on COX-2 and mPGES-1 expression in LPS-induced RAW264.7 cells]. Wang XG; Chen GY; Chen MP Zhong Yao Cai; 2007 Oct; 30(10):1263-6. PubMed ID: 18300499 [TBL] [Abstract][Full Text] [Related]
18. Coordinated up-regulation of cyclooxygenase-2 and microsomal prostaglandin E synthase 1 transcription by nuclear factor kappa B and early growth response-1 in macrophages. Díaz-Muñoz MD; Osma-García IC; Cacheiro-Llaguno C; Fresno M; Iñiguez MA Cell Signal; 2010 Oct; 22(10):1427-36. PubMed ID: 20546888 [TBL] [Abstract][Full Text] [Related]
19. Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines. van Rees BP; Sivula A; Thorén S; Yokozaki H; Jakobsson PJ; Offerhaus GJ; Ristimäki A Int J Cancer; 2003 Nov; 107(4):551-6. PubMed ID: 14520691 [TBL] [Abstract][Full Text] [Related]
20. Characterization of microsomal prostaglandin E synthase 1 inhibitors. Korotkova M; Jakobsson PJ Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):64-9. PubMed ID: 24138533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]